These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 4374143)

  • 21. [Molecular physiology of adrenoreceptors].
    Govyrin VA; Zhorov BS
    Fiziol Zh SSSR Im I M Sechenova; 1984 May; 70(5):529-51. PubMed ID: 6088303
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacological considerations for conscious sedation: clinical applications of receptor function.
    Becker DE
    Anesth Prog; 1991; 38(2):33-8. PubMed ID: 1667349
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neuroleptic affinities for human brain receptors and their use in predicting adverse effects.
    Richelson E
    J Clin Psychiatry; 1984 Aug; 45(8):331-6. PubMed ID: 6146602
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Quantitative aspects of alpha adrenergic effects induced by clonidine-like imidazolidines. II. Central and peripheral bradycardic activities.
    de Jonge A; Timmermans PB; van Zwieten PA
    J Pharmacol Exp Ther; 1982 Sep; 222(3):712-9. PubMed ID: 6125587
    [No Abstract]   [Full Text] [Related]  

  • 25. [Adrenoreceptors of the heart].
    Matiushin AI
    Farmakol Toksikol; 1986; 49(1):107-13. PubMed ID: 3005030
    [No Abstract]   [Full Text] [Related]  

  • 26. A dopaminergic-cholinergic mechanism in production of psychotic symptoms.
    Friedhoff AJ; Alpert M
    Biol Psychiatry; 1973 Apr; 6(2):165-9. PubMed ID: 4709131
    [No Abstract]   [Full Text] [Related]  

  • 27. Drug receptors: considerations of their functional properties in disease and pharmacologic intervention.
    Taylor P
    Drug Ther; 1982; ():121-38. PubMed ID: 7049649
    [No Abstract]   [Full Text] [Related]  

  • 28. Two or more conformations of benzodiazepine receptors depending on GABA receptors and other variables.
    Braestrup C; Nielsen M; Krogsgaard-Larsen P; Falch E
    Adv Biochem Psychopharmacol; 1980; 21():301-12. PubMed ID: 6246746
    [No Abstract]   [Full Text] [Related]  

  • 29. The use of rigid analogues to probe hallucinogen receptors.
    Nichols DE; Weintraub HJ; Pfister WR; Yim GK
    NIDA Res Monogr; 1978; (22):70-83. PubMed ID: 101889
    [No Abstract]   [Full Text] [Related]  

  • 30. Phenyliminoimidazolidines. Characterization of a class of potent agonists of octopamine-sensitive adenylate cyclase and their use in understanding the pharmacology of octopamine receptors.
    Nathanson JA
    Mol Pharmacol; 1985 Sep; 28(3):254-68. PubMed ID: 2993848
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Adaptive changes in functions of brain neurotransmitter receptors, evoked by repeated administration of antidepressant drugs.
    Przegaliński E
    Acta Physiol Pol; 1987; 38(5):373-85. PubMed ID: 2839008
    [No Abstract]   [Full Text] [Related]  

  • 32. [Clinico-pharmacological aspects of endogenous physiologically active compounds].
    Mashkovskiĭ MD
    Klin Med (Mosk); 1990 Apr; 68(4):3-15. PubMed ID: 1695261
    [No Abstract]   [Full Text] [Related]  

  • 33. Pharmacology of neuroleptics in use in the United States.
    Richelson E
    J Clin Psychiatry; 1985 Aug; 46(8 Pt 2):8-14. PubMed ID: 2862140
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The influence of hormones on drug-induced modifications in neurotransmitter receptor binding.
    Kendall DA; Slopis J; Duman R; Stancel GM; Enna SJ
    Prog Clin Biol Res; 1982; 79():193-207. PubMed ID: 6124004
    [No Abstract]   [Full Text] [Related]  

  • 35. [Physiological mechanisms of the neurotropic effect of snake venoms].
    Orlov BN; Gelashvili DB; Omarov ShM; Korneva NV
    Usp Fiziol Nauk; 1979; 10(2):24-44. PubMed ID: 224610
    [No Abstract]   [Full Text] [Related]  

  • 36. Conformational drug determinants of the sequence specificity of drug-stimulated topoisomerase II DNA cleavage.
    Capranico G; Palumbo M; Tinelli S; Mabilia M; Pozzan A; Zunino F
    J Mol Biol; 1994 Jan; 235(4):1218-30. PubMed ID: 8308885
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Interaction of the novel antipsychotic drug amperozide and its metabolite FG5620 with central nervous system receptors and monoamine uptake sites: relation to behavioral and clinical effects.
    Svartengren J; Pettersson E; Björk A
    Biol Psychiatry; 1997 Aug; 42(4):247-59. PubMed ID: 9270901
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Use of dipole moment as a parameter in drug-receptor interaction and quantitative structure-activity relationship studies.
    Lien EJ; Guo ZR; Li RL; Su CT
    J Pharm Sci; 1982 Jun; 71(6):641-55. PubMed ID: 7097526
    [No Abstract]   [Full Text] [Related]  

  • 39. Receptors for amino acids in excitable tissues.
    Buu NT; Puil E; van Gelder NM
    Gen Pharmacol; 1976; 7(1):5-14. PubMed ID: 786776
    [No Abstract]   [Full Text] [Related]  

  • 40. Pharmacological receptors: the need for a compendium of classification, nomenclature and structure.
    Green JP
    Trends Pharmacol Sci; 1990 Jan; 11(1):13-6. PubMed ID: 2408208
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.